Obstetrics & Gynecology · Los Angeles, CA
NPI
1356352108
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
4618 Fountain Ave
Los Angeles, CA, 90029
Phone (323) 669-4346
Groups this clinician bills Medicare through
Medicare paid, 2024
$382K
3,611 services
Medicare patients, 2024
1,241
Average age 76
Drug cost, 2024
$389K
2,686 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen Pine was code 99214 (office e&m - established), 1,281 times for 995 patients. In total Stephen Pine billed 3,611 services in 16 codes, and Medicare paid $382K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,281 | 995 | $97.66 | $125K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 299 | 294 | $92.52 | $28K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 298 | 293 | $48.02 | $14K |
| 93925 Duplex Scan - Extremity Arteries | Office | 245 | 242 | $166.48 | $41K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 236 | 231 | $148.53 | $35K |
| 99204 Office E&M - New | Office | 225 | 225 | $125.68 | $28K |
| 93970 Duplex Scan - Extremity Veins | Office | 221 | 219 | $130.41 | $29K |
| 36415 Venipuncture Blood Collection | Office | 212 | 209 | $8.65 | $1,834 |
| 93886 Ultrasound - Nonspecific | Office | 168 | 167 | $221.65 | $37K |
| 93924 Duplex Scan - Extremity Arteries | Office | 149 | 149 | $132.94 | $20K |
| 93923 Duplex Scan - Extremity Arteries | Office | 148 | 148 | $107.16 | $16K |
| 99213 Office E&M - Established | Office | 64 | 60 | $66.89 | $4,281 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 28 | 28 | $42.52 | $1,190 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 24 | 22 | $33.69 | $809 |
| 99203 Office E&M - New | Office | 12 | 12 | $87.31 | $1,048 |
By year: 2022 $170K for 1,725 services; 2023 $307K for 3,161 services; 2024 $382K for 3,611 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 212 | 209 | $8.65 | $1,834 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen Pine prescribed most often to Medicare patients was Atorvastatin Calcium, with 194 prescriptions and refills. In total Stephen Pine wrote 2,686 Medicare prescriptions that cost $389K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 194 | 197 | 72 | $1,765 |
| Metformin Hcl Generic | 122 | 125 | 51 | $1,438 |
| Amlodipine Besylate Generic | 94 | 94 | 39 | $478 |
| Omeprazole Generic | 76 | 76 | 33 | $463 |
| Levothyroxine Sodium Generic | 65 | 65 | 20 | $594 |
| Tamsulosin Hcl Generic | 65 | 65 | 31 | $410 |
| Eliquis Apixaban | 65 | 69 | 27 | $38K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 50 | 53 | 25 | $1,889 |
| Furosemide Generic | 48 | 50 | 19 | $145 |
| Losartan Potassium Generic | 43 | 43 | 18 | $167 |
| Gabapentin Generic | 40 | 40 | 18 | $1,069 |
| Lisinopril Generic | 38 | 38 | 15 | $222 |
| Fluticasone Propionate Generic | 36 | 40 | 14 | $686 |
| Rosuvastatin Calcium Generic | 34 | 34 | 13 | $300 |
| Metoprolol Succinate Generic | 34 | 37 | 14 | $170 |
Brand drugs: 528 claims; generic drugs: 2,115 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Stephen Pine were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.